Avaleht › Haavandiline koliit › Washington › Tacoma
Haavandiline koliit kliinilised uuringud linnas Tacoma, WA
15 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid linnas Tacoma ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
VärbamineFaas 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
VärbamineFaas 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
VärbamineFaas 2
- Site 019, Tacoma
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 2
- Site US-029, Tacoma
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 3
- GI Alliance Tacoma, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
VärbamineFaas 2/3
- MultiCare Health System, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
VärbamineFaas 3
- Washington Gastroenterology - Tacoma, Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 2
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
VärbamineFaas 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 3
- GI Alliance Tacoma, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
VärbamineFaas 2
- Digestive Health Specialists, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
VärbamineFaas 3
- MultiCare Institute for Research & Innovation, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
VärbamineVaatlusuuring
- Washington Gastroenterology, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
VärbamineFaas 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
VärbamineFaas 2
- Mirador Therapeutics Selected Site, Tacoma
Haavandiline koliit uuringud teistes linnades
- New York City, NY23 uuringut
- Orlando, FL22 uuringut
- Miami, FL21 uuringut
- Houston, TX17 uuringut
- San Antonio, TX16 uuringut
- Chicago, IL15 uuringut
- San Diego, CA15 uuringut
- Tyler, TX14 uuringut
- Colorado Springs, CO14 uuringut
- Los Angeles, CA13 uuringut
- St. Louis, MO13 uuringut
- Washington, DC12 uuringut
Muud uuringud linnas Tacoma
- Mitteväikerakuline kopsuvähk20 uuringut
- Rinnavähk18 uuringut
- Müeloom13 uuringut
- Eesnäärmevähk11 uuringut
- Crohni tõbi11 uuringut
- Metastaatiline vähk9 uuringut
- Käär- ja pärasoolevähk9 uuringut
- Melanoom7 uuringut
- Munasarjavähk7 uuringut
- Vähk (kõik liigid)6 uuringut
- Pankreasevähk6 uuringut
- Rasvumine6 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.